Abstract:BackgroundInhibition of sphingosine kinase 1 (SphK1), which catalyzes bioactive lipid sphingosine-1–phosphate (S1P), attenuates NLRP3 inflammasome activation. S1P exerts most of its function by binding to S1P receptors (S1PR1-5). The roles of S1P receptors in NLRP3 inflammasome activation remain unclear.Materials and methodsThe mRNA expressions of S1PRs in bone marrow-derived macrophages (BMDMs) were measured by real-time quantitative polymerase chain reaction (qPCR) assays. BMDMs were primed with LPS and stimulated with NLRP3 activators, including ATP, nigericin, and imiquimod. Interleukin-1β (IL-1β) in the cell culture supernatant was detected by enzyme-linked immunosorbent assay (ELISA). Intracellular potassium was labeled with a potassium indicator and was measured by confocal microscopy. Protein expression in whole-cell or plasma membrane fraction was measured by Western blot. Cecal ligation and puncture (CLP) was induced in C57BL/6J mice. Mortality, lung wet/dry ratio, NLRP3 activation, and bacterial loads were measured.ResultsMacrophages expressed all five S1PRs in the resting state. The mRNA expression of S1PR3 was upregulated after lipopolysaccharide (LPS) stimulation. Inhibition of S1PR3 suppressed NLRP3 and pro-IL-1β in macrophages primed with LPS. Inhibition of S1PR3 attenuated ATP-induced NLRP3 inflammasome activation, enhanced nigericin-induced NLRP3 activation, and did not affect imiquimod-induced NLRP3 inflammasome activation. In addition, inhibition of S1PR3 suppressed ATP-induced intracellular potassium efflux. Inhibition of S1PR3 did not affect the mRNA or protein expression of TWIK2 in LPS-primed BMDMs. ATP stimulation induced TWIK2 expression in the plasma membrane of LPS-primed BMDMs, and inhibition of S1PR3 impeded the membrane expression of TWIK2 induced by ATP. Compared with CLP mice treated with vehicle, CLP mice treated with the S1PR3 antagonist, TY52156, had aggravated pulmonary edema, increased bacterial loads in the lung, liver, spleen, and blood, and a higher seven-day mortality rate.ConclusionsInhibition of S1PR3 suppresses the expression of NLRP3 and pro-IL-1β during LPS priming, and attenuates ATP-induced NLRP3 inflammasome activation by impeding membrane trafficking of TWIK2 and potassium efflux. Although inhibition of S1PR3 decreases IL-1β maturation in the lungs, it leads to higher bacterial loads and mortality in CLP mice.

Tyrosine phosphorylation of NLRP3 by the Src family kinase Lyn suppresses the activity of the NLRP3 inflammasome

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

Tyrosine Phosphatase SHP2 Negatively Regulates NLRP3 Inflammasome Activation Via ANT1-dependent Mitochondrial Homeostasis

Double remote electrochemical addressing and optical readout of electrochemiluminescence at the tip of an optical fiber.

Non-Lyn Src Family Kinases Activate SIRPα-SHP-1 to Inhibit PI3K-Akt2 and Dampen Proinflammatory Macrophage Polarization

Regulation of NLRP3 Inflammasome by Phosphorylation

Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitis

NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain

Hematopoietic Cell Kinase (HCK) Is Essential for NLRP3 Inflammasome Activation and Lipopolysaccharide-Induced Inflammatory Response In Vivo

The Inhibitor Effect of RKIP on Inflammasome Activation and Inflammasome-Dependent Diseases

Acetylation is required for full activation of the NLRP3 inflammasome

SIRT3-mediated deacetylation of NLRC4 promotes inflammasome activation

NLRP3 Inflammasome Inhibitor INF39 Attenuated NLRP3 Assembly in Macrophages.

Inhibition of Sphingosine-1-phosphate Receptor 3 Suppresses ATP-induced NLRP3 Inflammasome Activation in Macrophages Via TWIK2-mediated Potassium Efflux

AKT Controls NLRP3 Inflammasome Activation by Inducing DDX3X Phosphorylation

NLRP3 Phosphorylation is an Essential Priming Event for Inflammasome Activation.

Carcinoembryonic antigen-related cell adhesion molecule 1 down regulates Syk coupled neutrophil NLRP3 inflammasome activation through ITIM and the recruitment of SHP-1 (157.12)

Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides.

Cutting Edge: TRAF6 Mediates TLR/IL-1R Signaling–Induced Nontranscriptional Priming of the NLRP3 Inflammasome

The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse Model

The CARD8 T60 variant associates with NLRP1 and negatively regulates its activation